Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma

NCT04417660 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

NIH

Sponsor class

Conditions

Thymic Epithelial Tumor
Recurrent Thymoma
Thymic Cancer

Interventions

DRUG: M7824

Sponsor

National Cancer Institute (NCI)